Who is sponsoring NCT04052490?

NCT04052490 is sponsored by Cairo University.

What drugs are being tested in NCT04052490?

Interventions in NCT04052490: Abutment with flat occlusal reduction with feather edge finish.

What condition does NCT04052490 study?

NCT04052490 studies Gingival Inflammation.

Is NCT04052490 still recruiting?

NCT04052490 is currently completed. Last updated 15 April 2022.

Last reviewed 2022-04-15 · How we verify

NCT04052490

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation Of Zirconia Crowns Restoring Endodontically Treated Posterior Teeth With Two Finish Line Designs And Occlusal Reduction Schemes

Completed NA Last updated 15 April 2022

What this trial tests

NA trial testing Abutment with flat occlusal reduction with feather edge finish in Gingival Inflammation in 66 participants. Completed in 1 October 2021.

Timeline

1 October 2019

Primary endpoint
31 July 2021

1 October 2021

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	66
Start date	1 October 2019
Primary completion	31 July 2021
Estimated completion	1 October 2021
Sites	1 location across Egypt

Drugs / interventions tested

Abutment with flat occlusal reduction with feather edge finish

Conditions studied

Gingival Inflammation — all drugs for Gingival Inflammation →

Sponsor

Cairo University

Who can join

Adults 20 to 50, any sex, with Gingival Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the clinical performance of two finish line designs (feather edge and rounded shoulder) in relation with two occlusal designs (flat and planar) in endodontically treated teeth restored with zirconia crowns.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gingival Inflammation

Currently open trials in the same condition.

NCT07104019 — Biofiller and Gingival Phenotype Thickening · NA · recruiting
NCT07100574 — Bacteria in Dental Plaque and Atheroma Plaque · recruiting
NCT06752291 — EFFECTIVENESS of WATER FLOSS in PLAQUE REMOVAL and PREVENTION of WHITE SPOT LESIONS in ORTHODONTIC PATIENTS: a RANDOMISE · NA · active not recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04052490 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 15 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04052490.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing